Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib can help about 14,000 people with severe hair loss.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Bimekizumab effectively treated a man's chronic beard hair loss.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

RNase L hinders hair follicle regeneration by altering immune signals.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.